A study of the clinical activity of a gel combining monocaprin and doxycycline: A novel treatment for herpes labialis

Journal of Oral Pathology and Medicine

Volumn 41, Issue 1, 2012, Pages 61-67

  Skulason, Skuli ^a,b   Holbrook, W Peter ^a   Thormar, Halldor ^a   Gunnarsson, Gunnar B ^c   Kristmundsdottir, Thordis ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Bio Gels Pharmaceuticals   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Doxycycline; Herpes labialis; Hydrogel; Matrix metalloproteinase; Monocaprin

Indexed keywords

ANTIVIRUS AGENT; DOXYCYCLINE; MONOCAPRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HERPES LABIALIS; HUMAN; HYDROGEL; IN VIVO STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PAIN; PRIORITY JOURNAL; WOUND HEALING;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; BLISTER; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG CARRIERS; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GLYCERIDES; HERPES LABIALIS; HUMANS; HYDROGEL; MALE; MATRIX METALLOPROTEINASES; MEDICAL RECORDS; MIDDLE AGED; PAIN MEASUREMENT; PLACEBOS; SIMPLEXVIRUS; STOMATITIS, APHTHOUS; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 84855425425     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01037.x     Document Type: Article

References (22)

1. Holbrook WP, Gudmundsson GT, Ragnarsson KT. Herpetic gingivostomatitis in otherwise healthy adolescents and young adults. Acta Odontol Scand 2001; 59: 113-5.
2. Brown TJ, Mccrary M, Tyring SK. Antiviral agents: nonantiviral drugs. J Am Acad Dermatol 2002; 47: 581-99.
3. Sacks SL, Thisted RA, Jones TM, et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001; 45: 222-30.
4. Miller CS, Danaher RJ, Jacob RJ. Molecular aspects of herpes simplex virus - I - latency, reactivation, and recurrence. Crit Rev Oral Biol Med 1998; 9: 541-62.
5. Openshaw H, Mcneill JI, Lin XH, Niland J, Cantin EM. Herpes simplex Virus dna in normal corneas: Persistence without viral shedding from ganglia. J Med Virol 1995; 46: 75-80.
6. Scully C. Orofacial herpes-simplex virus-infections - current concepts in the epidemiology, pathogenesis, and treatment, and disorders in which the virus may be implicated. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1989; 68: 701-10.
7. Balfour HH. Antiviral drugs. N Engl J Med 1999; 340: 1255-68.
8. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001; 357: 1513-8.
9. Harmenberg J, Oberg B, Spruance S. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: a literature review. Acta Derm-Venereol 2010; 90: 122-30.
10. Field HJ. Herpes simplex virus antiviral drug resistance - current trends and future prospects. J Clin Virol 2001; 21: 261-9.
11. Golub LM, Lee HM, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodont Res 1983; 18: 516-26.
12. Skulason S, Holbrook WP, Kristmundsdottir T. Clinical assessment of the effect of a matrix metalloproteinase inhibitor on aphthous ulcers. Acta Odontol Scand 2009; 67: 25-9.
13. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T. Inactivation of enveloped viruses and killing of cells by fatty-acids and monoglycerides. Antimicrob Agents Chemother 1987; 31: 27-31.
14. Thormar H, Bergsson G, Gunnarsson E, et al. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex Transm Infect 1999; 75: 181-5.
15. Kristmundsdottir T, Arnadottir SG, Bergsson G, Thormar H. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient. J Pharm Sci 1999; 88: 1011-5.
16. Raborn GW, Martel AY, Lassonde M, et al. Effective treatment of herpes simplex labialis with penciclovir cream - combined results of two trials. J Am Dent Assoc 2002; 133: 303-9.
17. Haanpaa M. Controlled release oxycodone - an evidence-based treatment for pain in acute herpes zoster. Pain 2009; 142: 175-6.
18. Fiddian AP, Yeo JM, Stubbings R, Dean D. Successful treatment of herpes labialis with topical acyclovir. Br Med J 1983; 286: 1699-701.
19. Evans TG, Bernstein DI, Raborn GW, Harmenberg J, Kowalski J, Spruance SL. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother 2002; 46: 1870-4.
20. Boon R, Goodman JJ, Martinez J, et al. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Clin Ther 2000; 22: 76-90.
21. Spruance SL, Nett R, Marbury T, et al. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother 2002; 46: 2238-43.
22. Fiddian AP, Ivanyi L. Topical acyclovir in the management of recurrent herpes labialis. Br J Dermatol 1983; 109: 321-6.